This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) shed 6.18% to $7.44 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.70% to 4,357.73 and Dow Jones Industrial Average falling 1.78% to 33,970.47. The stock's fall snapped a two-day winning streak. Ocugen Inc. closed $11.33 below its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (ADVM) fell 3.03% to $2.24, Ocular Therapeutix Inc. (OCUL) fell 5.02% to $10.02, and Kodiak Sciences Inc. (KOD) fell 2.78% to $99.89. Trading volume (9.2 M) remained 4.6 million below its 50-day average volume of 13.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 20, 2021.
(END) Dow Jones Newswires
September 20, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.